334 related articles for article (PubMed ID: 37406595)
1. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
Yang YS; Smucny J; Zhang H; Maddock RJ
Neuroimage Clin; 2023; 39():103461. PubMed ID: 37406595
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic meta-analyses reveal novel metabolite profiles across methamphetamine and cocaine substance use disorder.
Smucny J; Maddock RJ
Drug Alcohol Depend; 2023 Jul; 248():109900. PubMed ID: 37148676
[TBL] [Abstract][Full Text] [Related]
3. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
4. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
Deicken RF; Johnson C; Pegues M
Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
[TBL] [Abstract][Full Text] [Related]
5. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
6. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
[TBL] [Abstract][Full Text] [Related]
7. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Kraguljac NV; Reid M; White D; Jones R; den Hollander J; Lowman D; Lahti AC
Psychiatry Res; 2012; 203(2-3):111-25. PubMed ID: 22981426
[TBL] [Abstract][Full Text] [Related]
8. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia.
Jarskog LF; Dong Z; Kangarlu A; Colibazzi T; Girgis RR; Kegeles LS; Barch DM; Buchanan RW; Csernansky JG; Goff DC; Harms MP; Javitt DC; Keefe RS; McEvoy JP; McMahon RP; Marder SR; Peterson BS; Lieberman JA
Neuropsychopharmacology; 2013 Jun; 38(7):1245-52. PubMed ID: 23325325
[TBL] [Abstract][Full Text] [Related]
9. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
10. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
11. MR-spectroscopy in metachromatic leukodystrophy: A model free approach and clinical correlation.
Feldmann J; Martin P; Bender B; Laugwitz L; Zizmare L; Trautwein C; Krägeloh-Mann I; Klose U; Groeschel S
Neuroimage Clin; 2023; 37():103296. PubMed ID: 36563646
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
14. Reduction of N-acetylaspartate in the medial prefrontal cortex correlated with symptom severity in obsessive-compulsive disorder: meta-analyses of (1)H-MRS studies.
Aoki Y; Aoki A; Suwa H
Transl Psychiatry; 2012 Aug; 2(8):e153. PubMed ID: 22892718
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
16. Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of
Iwata Y; Nakajima S; Plitman E; Mihashi Y; Caravaggio F; Chung JK; Kim J; Gerretsen P; Mimura M; Remington G; Graff-Guerrero A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():340-352. PubMed ID: 29580804
[TBL] [Abstract][Full Text] [Related]
17. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
18. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
[TBL] [Abstract][Full Text] [Related]
20. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
